[go: up one dir, main page]

GB202319843D0 - CAS13-based compositions and methods of use thereof - Google Patents

CAS13-based compositions and methods of use thereof

Info

Publication number
GB202319843D0
GB202319843D0 GBGB2319843.5A GB202319843A GB202319843D0 GB 202319843 D0 GB202319843 D0 GB 202319843D0 GB 202319843 A GB202319843 A GB 202319843A GB 202319843 D0 GB202319843 D0 GB 202319843D0
Authority
GB
United Kingdom
Prior art keywords
cas13
methods
based compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2319843.5A
Other versions
GB2622995A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Abdullah University of Science and Technology KAUST
Original Assignee
King Abdullah University of Science and Technology KAUST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2021/054664 external-priority patent/WO2021240443A1/en
Application filed by King Abdullah University of Science and Technology KAUST filed Critical King Abdullah University of Science and Technology KAUST
Publication of GB202319843D0 publication Critical patent/GB202319843D0/en
Publication of GB2622995A publication Critical patent/GB2622995A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB2319843.5A 2021-05-27 2022-05-27 CAS13-based compositions and methods of use thereof Pending GB2622995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163194099P 2021-05-27 2021-05-27
PCT/IB2021/054664 WO2021240443A1 (en) 2020-05-27 2021-05-27 Iscan: an rt-lamp-coupled crispr-cas module for rapid, sensitive detection of sars-cov-2
PCT/IB2022/055036 WO2022249152A2 (en) 2021-05-27 2022-05-27 Cas13-based compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
GB202319843D0 true GB202319843D0 (en) 2024-02-07
GB2622995A GB2622995A (en) 2024-04-03

Family

ID=82016483

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2319843.5A Pending GB2622995A (en) 2021-05-27 2022-05-27 CAS13-based compositions and methods of use thereof

Country Status (2)

Country Link
GB (1) GB2622995A (en)
WO (1) WO2022249152A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117701530A (en) * 2022-12-08 2024-03-15 广州瑞风生物科技有限公司 Cas protein truncate, method for constructing same and application thereof
CN117106101B (en) * 2023-10-20 2024-06-07 合肥百裕生物科技有限公司 Plasmid and ASFV protease inhibitor screening and drug effect evaluation method
CN118389648B (en) * 2024-04-30 2025-09-19 湖南师范大学 Method for identifying single nucleotide polymorphism based on crRNA spacer cleavage and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071048A1 (en) 2017-10-04 2019-04-11 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing

Also Published As

Publication number Publication date
GB2622995A (en) 2024-04-03
WO2022249152A2 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
IL309073A (en) Enantiomeric entactogen compositions and methods of their use
SG11202111387YA (en) Oligonucleotide compositions and methods of use thereof
SG11202111386UA (en) Oligonucleotide compositions and methods of use thereof
IL281082A (en) Compositions of cxcr4 inhibitors and methods of preparation and use
SI4267105T1 (en) Antibody compositions and methods of use thereof
IL276135A (en) Compositions and methods of use
IL285247A (en) Enhanced nitrate compositions and methods of use
GB202319843D0 (en) CAS13-based compositions and methods of use thereof
ZA202100780B (en) Bismuth-thiol compositions and methods of use
IL308041A (en) Collagen compositions and methods of use thereof
EP4121224A4 (en) Cleaning compositions and methods of use thereof
IL299245A (en) Lair-1-binding agents and methods of use thereof
IL312928A (en) Complement factor b-modulating compositions and methods of use thereof
EP4204004A4 (en) Anti-idiotype compositions and methods of use thereof
IL287797A (en) Oligosaccharide compositions and methods of use
EP4381022A4 (en) Compositions and methods of use thereof
IL315862A (en) Angiotensinogen-modulating compositions and methods of use thereof
IL312205A (en) Coxsackievirus b compositions and methods of use thereof
IL316049A (en) Pharmaceutical compositions of mosunetuzumab and methods of use
IL324171A (en) Mivelsiran compositions and methods of use thereof
IL323920A (en) Mapt-modulating compositions and methods of use thereof
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
GB201919385D0 (en) Compositions and methods of manufacture
HK40114450A (en) Angiotensinogen-modulating compositions and methods of use thereof